|Phone||41 61 688 11 11|
|Description||Diagnostic Healthcare products|
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80’000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing (roche.com) 
Roche Acquires BioImagene, a Leading Provider of Digital Pathology Laboratory Solutions (bioimagene.com) 
Cap Funding Report 
Roche Holding AG acquires Mirus Bio Corp (alacrastore.com) 
Roche acquires antibody research co., THP, for $56.5M (deals.venturebeat.com)